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Abstract
Hepcidin regulation by competing stimuli such as infection and iron deficiency has not been studied in infants and it’s yet
unknown whether hepcidin regulatory pathways are fully functional in infants. In this cross-sectional study including 339
Kenyan infants aged 6.061.1 months (mean6SD), we assessed serum hepcidin-25, biomarkers of iron status and
inflammation, and fecal calprotectin. Prevalence of inflammation, anemia, and iron deficiency was 31%, 71%, 26%,
respectively. Geometric mean (6SD) serum hepcidin was 6.0 (63.4) ng/mL, and was significantly lower in males than
females. Inflammation (C-reactive protein and interleukin-6) and iron status (serum ferritin, zinc protoporphyrin and soluble
transferrin receptor) were significant predictors of serum hepcidin, explaining nearly 60% of its variance. There were small,
but significant differences in serum hepcidin comparing iron deficient anemic (IDA) infants without inflammation to iron-
deficient anemic infants with inflammation (1.2 (64.9) vs. 3.4 (64.9) ng/mL; P,0.001). Fecal calprotectin correlated with
blood/mucus in the stool but not with hepcidin. Similarly, the gut-linked cytokines IL-12 and IL-17 did not correlate with
hepcidin. We conclude that hepcidin regulatory pathways are already functional in infancy, but serum hepcidin alone may
not clearly discriminate between iron-deficient anemic infants with and without infection. We propose gender-specific
reference values for serum hepcidin in iron-replete infants without inflammation.
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Introduction
Hepcidin, a 25-amino acid peptide produced and secreted
mainly by hepatocytes, is a major regulator of systemic iron
homeostasis [1,2]. Hepcidin regulates iron efflux from macro-
phages and enterocytes through its binding to ferroportin and
subsequent internalization of the receptor-ligand complex [3,4]. It
may also reduce intestinal iron absorption through ubiquitin-
dependent proteasome degradation of divalent metal transporter 1
(DMT1) on the luminal enterocyte membrane [5].
Serum hepcidin transcription is decreased in iron deficiency,
hypoxia and by erythropoietic stimuli, and it is increased in
infection, inflammation and iron overload [2,6–8]. Iron status
regulates hepcidin expression primarily through the bone
morphogenic protein/hemojuvelin (BMP/HJV) pathway, while
infection and inflammatory cytokines such as interleukin-6 (IL-6)
increase hepcidin transcription mainly through the Janus kinase/
signal transducers and activators of transcription (JAK/STAT)
pathway [9,10].
The regulation of circulating hepcidin by concurrent and
competing stimuli such as infection and iron deficiency has not
been extensively studied in humans. Infants, particularly in low-
income countries, are highly vulnerable to both, serious infections
and iron deficiency [11]. Hepcidin may be a sensitive marker for
iron utilization and absorption, but little data is available on
hepcidin concentration and its relationship to established markers
in population studies. A previous study in anemic Tanzanian
children, aged 2 months to 13 years, showed high concentrations
of urine hepcidin were associated with malaria, which could
contribute to malarial anemia and an impaired erythropoietic
response to iron supplementation [12]. In addition it was shown,
that asymptomatic malarial parasitemia was associated with
increased serum hepcidin concentrations and anemia in Indone-
sian schoolchildren, aged 5–15 years [13]. Moreover, a recent
study in anemic Gambian children, aged 1.5–3 years, showed, that
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serum hepcidin was the major predictor of erythrocyte iron
incorporation [14]. Together, these studies advocate a low-cost
hepcidin assay to improve safety and efficacy of iron supplemen-
tation programs for children in developing countries. However, no
published data are yet available on how inflammation and iron
status interact to determine serum hepcidin concentrations in very
young infants at the age of 6 month. As immune responses and
hepatic metabolism are not fully mature in early infancy, hepcidin
regulatory pathways may not yet be fully functional. Moreover,
although reference values for serum hepcidin have been proposed
for adults [15], there are no published data on serum hepcidin
concentrations in healthy, iron sufficient, non-anemic infants.
Therefore, the aims of this study were to (a) investigate how iron
status and inflammation interact to predict serum hepcidin
concentrations in African infants, aged 6 month, in a low-income
rural setting; and (b) propose a reference values for serum hepcidin
in healthy, term, iron sufficient African infants.
Methods
Ethics Statement
Ethical approval was given by committees at the Kenyatta
National Hospital/University of Nairobi (KNH-ERC/A/337), the
University of KwaZulu-Natal (BF121/08), and the Swiss Federal
Institute of Technology Zurich (EK 2009-N-53). Written informed
consent was obtained from the care-givers. The trial was registered
at clinicaltrials.gov (NCT01111864).
Study Population and Design
We conducted a cross-sectional study as part of an iron
intervention trial in Kenyan infants. From February 2010 to
August 2011, we recruited 5–7 months old infants (n = 339) in the
rural Msambweni district of southern coastal Kenya. The study
period included two long rainy seasons from April to July (2010
and 2011) and a short rainy season from October to November
2010. Most families in this area live from subsistence farming with
maize as the staple crop.
Malaria, fever, and diarrhea morbidity over the previous 3
months was assessed by questionnaire from mother’s recall, with a
focus on the previous 1 week and on the day of sample collection
(confirmed by health personnel). Feeding history (breastfeeding
and complementary feeding) was assessed via mother’s recall. The
antenatal card (n= 148) or mothers’ recall was used to record birth
history and included mode of delivery, birth date and birth weight.
Preterm birth was defined as registered birth before the 37th week
of gestation. Infant weight was measured to the nearest 100 g
using a hanging scale (Salter model number 235-6S, 25 kg6100 g;
Salter Brecknell, UK) and height to the nearest 0.1 cm using a
measurement board (Shorr Production, LLC., Olney, MD). A
whole blood sample was taken by venipuncture in the infants and
a finger prick was done to measure the hemoglobin in their
mothers. In a subgroup of infants (n = 148) we collected a stool
sample.
Laboratory Methods
Hemoglobin (Hb) was measured by using a HemoCue
(HemoCue AB, A¨ngelholm, Sweden) or a HemoControl device
(EKF diagnostics Sales GmbH, Barleben/Magdeburg, Germany)
from a venous blood sample (3 mL) in the infants or a finger prick
in their mothers. Serum was separated by centrifugation on
collection day. The remaining erythrocytes were washed 3 times
with normal saline and the zinc protoporphyrin to heme ratio
(ZPP) was measured by using a calibrated AVIV hematofluorom-
eter (AVIV Biomedical, Lakewood, USA). Serum ferritin (SF),
soluble transferrin receptor (sTfR) and C-reactive protein (CRP)
were measured at Lancet Laboratories Nairobi by using the Cobas
Integra (Roche, Basel, Switzerland). The lower limit of detection
(LLOD) for CRP was 0.9 mg/L. The following cut-offs were used:
(a) anemia: Hb ,110 g/L for infants and ,120 g/L for adult
women [16], (b) iron deficiency: SF ,12 ng/mL [16] or sTfR
$7.4 mg/L [17], and (c) elevated CRP: $4.1 mg/L (manufac-
turer’s reference range).
Frozen serum was transported to the Netherlands (Radboud
University Medical Centre, Nijmegen) and serum hepcidin
measurements were performed by a combination of weak cation
exchange chromatography and time-of-flight mass spectrometry
(WCX-TOF MS) [18]. An internal standard (synthetic hepcidin-
24; Peptide International Inc.) was used for quantification [19].
Peptide spectra were generated on a Microflex LT matrix-
enhanced laser desorption/ionisation TOF MS platform (Bruker
Daltonics). Serum hepcidin-25 concentrations were expressed as
nM and calculated to ng/mL (1 nM=2.789 ng/mL). The LLOD
of this method was 0.5 nM or 1.4 ng/mL, respectively. For
comparison of WCX-TOF MS generated data with a previously
used enzyme-linked immune-sorbent assay (ELISA) [15], hepcidin
values were recalculated using the equation (ELISA-1.00)/
1.52=WCX-TOF MS determined by Kroot et al. [18].
Serum levels of human IL-1b, IL-2, IL-4, IL-5, IL-6, IL-8, IL-
10, IFNc, TNFa, and GM-CSF were determined in 156 infants by
using a human cytokine multiplex kit (Cytokine 10-plex panel,
Invitrogen, Breda, Netherlands) according to the manufacturer’s
instructions. The LLOD of these cytokine assays was 15 pg/mL,
10 pg/mL, 5 pg/mL, 3 pg/mL, 3 pg/mL, 10 pg/mL, 5 pg/mL,
15 pg/mL, 5 pg/mL, 10 pg/mL, respectively. Serum levels of
human IL-12 (p40/p70) and IL-17 were determined in 39 samples
by using Singleplex bead kits (Invitrogen), also according to the
manufacturer’s instructions. The LLODs were 15 pg/mL and
20 pg/mL, respectively.
Stool samples were stored at 220uC until analysis. Fecal
calprotectin, a marker for intestinal inflammation, was measured
in 148 stool samples using an ELISA (Calprest, Eurospital, Trieste,
Italy).
Statistical Analysis
All data were analyzed using IBM SPSS Statistics 20.0.0 (SPSS
Inc., Chicago, IL) and Microsoft Office EXCEL 2010 (Microsoft,
Redmond, WA). Values for samples that were below the LLOD
for serum hepcidin, CRP and the cytokines were imputed using
randomly generated numbers between 0 and the specific LLODs.
Weight-for-age (WAZ), height-for-age (HAZ), weight-for-height
(WHZ), and BMI-for age (BAZ) z-scores were calculated using the
WHO Anthro software (version 3.2.2) and standards. Definition
for stunting was a HAZ,-2 and for wasting a WHZ,-2 [20].
The distribution of the data was checked for normality and log
transformation was performed, if needed, on non-normally
distributed data and for the calculation of the geometric means
(GM). Spearman correlation coefficients (rho) were determined to
assess the relationship of serum hepcidin with iron status,
inflammation and morbidities. Independent samples t-test and
the Mann-Whitney U were used to compare serum hepcidin, iron
status indices, and CRP values among groups. To explore
associations between hepcidin, iron status, and inflammation,
linear regression models were fitted with hepcidin, Hb, SF, sTfR,
ZPP as the dependent variables. In iron replete (SF $12 ng/mL
and sTfR ,7.4 mg/L), non-anemic (Hb $110 g/L), full-term
infants without inflammation (elevated CRP), reference values for
serum hepcidin were calculated and presented as geometric means
(GM) and the 2.5 and 97.5 percentiles (P2.5 and P97.5).
Predictors of Serum Hepcidin in Infants
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Results
Study Population
The sample included 339 mother-infant pairs. Mean (6SD)
maternal age was 26 (66.4) years, body mass index (BMI) was 21.3
(63.1) kg/m2, and Hb was 116.9 (611.7) g/L; nearly half (49.2%)
of the women were anemic. Among the mothers, 95.9% were
breastfeeding (n = 325) and 86.4% (n= 293) were giving comple-
mentary foods, predominantly sweetened maize gruel (‘‘uji’’),
starting from four months post-delivery. Of the infants, 61.9%
were born at home, 33.9% in hospital; 3.5% were preterm and
1.8% were delivered by Caesarian section. Mean (6SD) age of the
infants at assessment was 6.0 (61.1) months, and mean weight-for-
age and height-for-age z-scores were 20.4 and 20.8, respectively;
4.1% of infants were wasted and 14.7% were stunted. The
prevalence of anemia, iron deficiency and IDA was high: 70.5%,
25.4% and 22.4%, respectively (Table 1).
Infectious Diseases
There was a high burden of infectious disease among the
infants. Systemic inflammation (elevated CRP) was present in
nearly one-third (30.7%) of infants, and 119 (35.1%) had a CRP
below the LLOD of 0.9 mg/L. Based on maternal reports, 6.2%
of infants were currently passing watery or loose stools, 1.5% were
passing more than 4 stools a day, and 17.1% reported blood or
mucus in the stools. One infant had malaria on the day of the
venipuncture (assessed by a Giemsa stained blood smear), and
7.4% of infants had had malaria in the previous 3 months
(reported by caretaker). Mothers reported 8% of infants had
received antibiotics, 2.9% supplements for diarrhea, and 2.7%
treatment for intestinal parasites (reported as ‘‘worms’’) within the
previous week.
Serum Hepcidin and its Interaction with Biochemical,
Anthropometric and Health Markers
Among infants, geometric mean (GM, (6SD)) serum hepcidin
was 6.0 (63.4) ng/mL (Table 1), and was below the lower
limit of detection (LLOD) in 51 (15.0%) infants. Serum hepcidin
was significantly lower in males than in females (GM (6SD) 4.9
(63.5) ng/mL vs. 7.2 (63.3) ng/mL; P,0.05; Figure 1, (1)
total population). Infants born preterm had significantly lower
serum hepcidin (0.7 (67.0) ng/mL (58% below LLOD) vs. 7.1
(63.9) ng/mL (13% below LLOD); P,0.05) and higher ZPP
values (143.7 (61.9) mol/mol heme vs. 83.8 (61.8) mol/mol
heme; P,0.05) compared to full-term infants. There were no
statistically significant differences in Hb, SF, TfR and CRP
concentrations comparing preterm to term infants, but these
comparisons were limited as only 3.5% of infants were known
to be born preterm.
Serum hepcidin was significantly correlated with Hb, ZPP, SF,
sTfR, CRP, IL-6, weight, height, gender and premature birth
(Table 2). There were no significant correlations of serum
hepcidin with maternal Hb, place of delivery (hospital or home) or
infectious disease history. In the multiple linear regression analyses
including gender and weight-for-age z-score (WAZ); CRP
(b= .273), IL-6 (b= .221), ZPP (b=2.337), and SF (b= .274)
were significant predictors of serum hepcidin, resulting in an
adjusted R2 of.595 (P,0.001; Table 3). CRP and IL-6 together
explained 22.8% of the variance in serum hepcidin (adjusted
R2= .228). Omitting CRP and IL-6 from the model, the
remaining iron biomarkers explained 36.7% of the variance in
serum hepcidin (adjusted R2= .367). Replacing ZPP with sTfR
(b=2.202, P,0.001) did not change the predictive power of the
model. ZPP and sTfR correlated strongly (Spearman coefficient
rho= .628, P,0.001; Table 2), and including one of these
predictors in the regression model explained nearly the same
variance in serum hepcidin as both together. IL-6 was the only
cytokine with a significant correlation with hepcidin (rho= .358;
P,0.01, Table 2); moreover IL-6 correlated with SF (rho= .210;
P,0.01) and CRP (rho= .554; P,0.01). IL-5 correlated with Hb
(rho=2.176; P,0.05), and IL-12 with SF (rho=2.364; P,0.05).
Most interleukins correlated with CRP, but not with serum
hepcidin (Table 4).
The gender-specific regression models had a R2 of.553
and.586 in male and female infants respectively (Table 3).
Serum ferritin was a stronger predictor of hepcidin in females
(b= .297, P,0.001) than in males (b= .265, P,0.05), while
CRP was a slightly stronger predictor of hepcidin in males
(b= .288, P,0.001) compared to females (b= .257, P,0.001).
WAZ was a significant predictor (P,0.05) for hepcidin in the
total population and in female infants, but not in male infants.
CRP correlated significantly with SF (rho= .251; P,0.01), Hb
(rho=2.144; P,0.01), and hepcidin (rho= .426; P,0.01), but not
with sTfR and ZPP. Figure 2 shows scatterplots of hepcidin with
inflammation and iron markers. Separate linear regression
analyses with the iron markers (Hb, SF, sTfR, ZPP and hepcidin)
as dependent variables and inflammation markers (CRP and
Table 1. Characteristics of the study population.
Variable Male Female Both
N 173 (51.0%) 166 (49.0%) 339
Age, months* 6.0 (1.1) 6.1 (1.1) 6.0 (1.1)
Hemoglobin, g/L* 102.2 (11.8) 103.6 (11.1) 102.9 (10.1)
ZPP, mmol/mol heme* 99.6 (1.8) 84.6 (1.8) 91.9 (1.8)
Serum ferritin, ng/mL*
All children 24.1 (2.5) 32.2 (2.7) 27.8 (2.6)
Children without inflammation{21.5 (2.5) 29.5 (2.6) 24.9 (2.6)
Soluble transferrin receptor,
mg/L*
5.8 (1.4) 5.4 (1.4) 5.6 (1.4)
C-reactive protein, mg/L* 1.7 (4.8) 2.3 (4.4) 2.0 (4.6)
Hepcidin, ng/mL*{ 4.9 (3.5) 7.2 (3.3) 6.0 (3.4)
IL-6, pg/mL* 11.9 (1.9) 11.7 (1.9) 11.8 (1.9)
Fecal calprotectin, mg/kg* 160.7 (2.1) 175.5 (2.2) 167.1 (2.1)
Inflammation{ 50 (28.9%) 57 (34.3%) 103 (30.7%)
Anemia1 132 (76.3%) 107 (64.5%) 239 (70.5%)
Iron deficiency (ID) | | 51 (29.8%) 35 (21.3%) 86 (25.7%)
SF ,12 ng/mL 31 (18.3%) 22 (13.6%) 53 (15.6%)
sTfR $7.4 mg/L 36 (20.5%) 23 (14.0%) 59 (17.4%)
Iron deficiency anemia (IDA)" 50 (29.2%) 29 (17.7%) 79 (23.6%)
Birth weight, kg 3.2 (1.2) 3.1 (1.2) 3.1 (1.2)
Height-for-age (z-score) 20.9 (1.2) 20.7 (1.2) 20.8 (1.2)
Weight-for-age (z-score) 20.4 (1.2) 20.4 (1.2) 20.4 (1.2)
BMI-for-age (z-score) 0.1 (1.2) 20.03 (1.3) 0.06 (1.3)
Maternal hemoglobin, g/L* 117.4 (11.5) 116.3 (12.0) 116.9 (11.7)
Estimates are mean (6SD) or number (%) unless indicated otherwise.
*geometric mean (6SD).
{CRP.4.1 mg/L.
{conversion factor: 1 ng/mL = 0.358 nM.
1Hb ,110 g/L.
| |SF ,12 ng/mL or sTfR $7.4 mg/L.
"Concurrent ID and Anemia.
doi:10.1371/journal.pone.0057513.t001
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cytokines) as independent variables, identified CRP as a significant
predictor for SF (b= .254; P,0.001), Hb (b=2.185; P= 0.001)
and hepcidin (b= .394; P,0.001), but not for sTfR and ZPP. CRP
and the cytokines together resulted in an R2 of.345 (P,0.05) for
the prediction of SF concentration, whereas sTfR and ZPP were
not predicted by CRP and cytokines.
Fecal Calprotectin
Geometric mean (6SD) of fecal calprotectin (FC) was 167
(61.0) mg/kg. Calprotectin did not correlate with any other
inflammation or iron marker, but it correlated significantly with
weight (rho=2.258; P,0.01) and the report of the mothers of
blood or mucus in stool (rho=2.256; P,0.01). Fecal calprotectin
values did not correlate with any other morbidity indices or the
Figure 1. Median levels, lower and upper quartile plus standard error, of serum hepcidin (ng/mL) by sex, measured in different
subgroups. Criteria for subgroups were as follows: (1) total population; (2) no iron deficiency (ID), no anemia, and no elevated CRP concentration;
(3) ID and anemia (IDA), but no elevated CRP concentration; (4) no ID and anemia, but elevated CRP concentration; (5) IDA and elevated CRP
concentration. Cut-offs were as follows: anemia: Hb ,110 g/L; ID: SF ,12 ng/mL or sTfR $7.4 mg/L; IDA: concurrent anemia and ID; no ID: SF
$12 ng/mL and sTfR ,7.4 mg/L; elevated CRP: CRP$4.1 mg/L. Note: all individuals with ID and no elevated CRP were anemic. Letters (a, b, c, d, e,
and f) indicate significant differences at P,0.05.
doi:10.1371/journal.pone.0057513.g001
Table 2. Spearman correlation coefficients (rho) from iron and inflammation markers and anthropometric data of the study
infants.
ZPP SF sTfR CRP Hepcidin IL-6 Gender BW Weight Height
Hb, g/L 2.498* .242* 2.431* 2.144* .186* 2.132 .107 .107 2.135{ .009
ZPP, mmol/mol heme 2 2.439* .628* 2.002 2.437* 2.001 .205{ 2.170{ .205* .010
SF, ng/mL 2 2 2.417* .251* .609* .210* .144* .201{ 2.195* 2.134{
sTfR, mg/L 2 2 2 .017 2.371* .065 2.158* 2.161 .130{ .056
CRP, mg/L 2 2 2 2 .426* .554* .122{ .014 2.037 2.056
Hepcidin, ng/mL 2 2 2 2 2 .358* .206 .131 2.232* 2.152*
IL-6, pg/mL 2 2 2 2 2 2 .011 .062 2.116 2.034
Gender, (m/f) 2 2 2 2 2 2 2 2.113 2.258* 2.243*
BW, kg 2 2 2 2 2 2 2 2 .213* .135
Weight, kg 2 2 2 2 2 2 2 2 2 .632*
*P,0.01;
{P,0.05; BW=birth weight.
doi:10.1371/journal.pone.0057513.t002
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duration of breastfeeding. Only four mothers reported current
diarrhea (reported as 4 or more loose stools a day) in their
children, in 3 of them FC values are available. There was a trend
for a significant correlation between diarrhea cases and FC
(rho=2.158; P= 0.06). Girls had slightly higher fecal calprotectin
values (GM (6 SD)) than boys, of 175.5 (61.0) mg/kg and 160.7
(61.0) mg/kg, respectively. Fecal calprotectin did not correlate
with the gut-linked cytokines IL-12 and IL-17 measured in serum,
and these cytokines did not correlate with hepcidin.
Subgroup Analysis of Serum Hepcidin According to Iron
and Inflammation Status
Figure1 showsgender-stratified serumhepcidinconcentration in
different subgroups based on inflammation (measured by CRP) and
iron status and anemia. Twenty-nine male and thirty-nine female
infants were iron sufficient, non-anemic and had no elevated CRP.
The reference values for serumhepcidin from thesewere 4.1 ng/mL
inmale and 9.0 ng/mL in female infants (Table 5). Serumhepcidin
(GM6SD) in iron deficient infants without elevated CRP were low
(1.0 (64.2) ng/mL and 1.5 (63.8) ng/mL for males and females
respectively);23outof the36males (63.9%)and9outof the18females
(50.0%) had serum hepcidin concentration below the detection limit
of 1.4 ng/mL. We found small, though significant differences in
mean hepcidin concentration comparing iron deficient anemic
infantswithout inflammation (3 inFigure1) to irondeficient anemic
infants with inflammation (5 in Figure 1; 1.2 (64.9) ng/mL vs. 3.4
(64.9) ng/mL; P,0.001).
Discussion
We are not aware of previous reports of serum hepcidin
(hepcidin-25) concentrations in young full-term infants. Previous
data on serum hepcidin in infancy is limited to measurements in
Table 3. Results of linear regression analyses for serum hepcidin (ng/mL) in the total population and by gender separately.
Total population Male Female
(n =141) (n=65) (n=76)
B SE B b B SE B b B SE B b
Constant 1.264 .274 .987 .471 1.606 .326
CRP, mg/L .168 .039 .273* .162 .059 .288{ .168 .058 .257{
IL26, pg/mL .306 .088 .221* .287 .141 .207{ .323 .122 .242{
ZPP, mmol/mol heme 2.574 .125 2.337* 2.390 .213 2.218 2.670 .163 2.414*
sTfR, mg/L 2.101 .157 2.044 2.126 .230 2.063 2.130 .246 2.050
SF, ng/mL .246 .056 .274* .267 .113 .265{ .244 .066 .297*
WAZ 2.052 .020 2.151{ 2.056 .027 2.187{ 2.051 .031 2.128
Gender .076 .043 .097 2 2 2 2 2 2
Note: Adjusted R2 Total = .595; Adjusted R2 Male = .553; Adjusted R2 Female = .586;
*P,0.001;
{P,0.05. The dependent variable hepcidin and the independent variables were log-transformed before inclusion in the models. Interpretation for these betas is as
follows: 1% change in the independent variable corresponds to a beta% change in the dependent variable.
doi:10.1371/journal.pone.0057513.t003
Table 4. Mean levels of cytokines and fecal calprotectin and their correlation with hepcidin and CRP.
Geometric mean (± SD) Correlation (rho) with Hepcidin Correlation (rho) with CRP
IL-1, pg/mL 18.5 (2.5) .023 .257{
IL-2, pg/mL 24.0 (1.6) .084 .261{
IL-4, pg/mL 12.0 (7.5) .086 .252{
IL-5, pg/mL 4.5 (1.7) .021 .159
IL-6, pg/mL 11.8 (1.9) .405* .538*
IL-8, pg/mL 42.5 (2.4) .190 .291*
IL-10, pg/mL 28.4 (1.5) .093 .265{
IFN-c, pg/mL 3.0 (3.7) 2.034 2.052
TNF-a, pg/mL 9.5 (2.7) 2.040 .088
GM-CSF, pg/mL 8.2 (3.1) 2.002 .194
IL-12, pg/mL 237.3 (2.0) .011 .179
IL-17, pg/mL 38.7 (2.1) .216 .383
Calprotectin, mg/kg 167.1 (2.1) 2.087 2.088
*P,0.01;
{P,0.05.
doi:10.1371/journal.pone.0057513.t004
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preterm infants, low birth weight newborns in cord blood and
children over the age of 18 months [13–15]. Pro-hepcidin
concentrations in healthy non-anemic Turkish infants were
reported to be 1186102.2 ng/mL (mean 6 SD) [21], although
it is questionable whether these reflect any physiological relevance
[22,23]. In our Kenyan male infants, hepcidin concentrations
were much lower than those previously found in 18–24 years old
Dutch men and adapted for the differences in methods (4.1 ng/
mL vs 14.9 ng/mL) [15]. In female Kenyan infants, however, we
found higher values (9.0 ng/mL vs 2.9 ng/mL) than in 18–24
years old women from the previously mentioned Dutch popula-
tion. Therefore, in contrast to serum hepcidin concentrations in
adults where males have generally higher values than females
[15,24], serum hepcidin in our study was found to be around 50%
higher in female infants than in males, after controlling for weight
and height. In our regression model including iron status (sTfR, SF
Figure 2. Scatter plots and regression equations derived from the correlation of inflammation markers (A: CRP and B: IL-6) and iron
markers (C: SF, D: sTfR, and E: ZPP) with serum hepcidin.
doi:10.1371/journal.pone.0057513.g002
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and ZPP) and inflammation markers (CRP and IL-6), gender is
not a significant predictor (Table 3). This gender difference in
hepdicin concentration can mainly be explained by the lower
overall iron status in males, and the higher CRP concentration in
females. Several studies have reported higher rates of anemia and
lower iron status in male compared to female infants [25–29],
which were attributed to gender-specific growth rates [26] or
hormone-mediated differences in iron metabolism [29]. However,
more research is needed to elucidate gender-differences in iron
status in infants. The percentage of exclusively breastfed infants
was slightly higher in males (6.6%) compared to females (3.1%).
Even if not statistically significant, the higher proportion of
breastfed boys may contribute to the lower prevalence of infection
in boys found in this population group; as breast milk has shown to
be protective against infectious diseases [30].
This study demonstrates that circulating hepcidin-25 concentra-
tions are strongly predicted by both infection/inflammationmarkers
(CRPand IL-6) and iron statusmarkers (SF,ZPPand sTfR) in infants
in rural sub-SaharanAfrica.These data suggest that the known adult
hepcidin regulatory pathways are functioning well as early as 6
monthsof age. Inflammationand iron status explainednearly60%of
the variance in serum hepcidin, with a roughly equal contribution
fromeach inthis setting:CRPandIL-6explained23%of thevariance
in serumhepcidin, SF alone (a reflection of both iron status and, as an
acute-phase protein, inflammation) explained 32% of the variance,
while ZPP and sTfR together explained 21% (ZPP alone 20% and
sTfR 12%, respectively). In a previous study, in cord blood from low
birth weight newborns and preterm infants, circulating hepcidin
concentration was also correlated with iron status [31,32]. Also in
Dutch adults, the strongest predictor of serum hepcidin was SF
(R2= .58 and R2= .62 in adult men and women, respectively),
followed by CRP [15], but infection/inflammation is much more
common inour sampleofKenyan infants.Notably, hepcidin levels in
iron deficient and anemic (IDA) children with elevated CRP were
significantly lower than those in non-anemic children with elevated
CRP. Although IDA children with inflammation tended to have
higher hepcidin levels compared to IDA children without inflam-
mation, thisdifferencewas significant inmale infantsonly (Figure1).
These findings suggest that the inflammation mediated stimuli
(through IL-6) are to a large extent overruled by iron demand and
erythropoiesis stimuli down regulating hepcidin synthesis.
Defining iron status in Sub-SaharanAfrica and other settings with
a high burden of infectious disease is difficult [33]. The use of SF is
limited by its confounding by inflammation, andZPP and sTfRhave
been proposed as preferable indices in these settings, although ZPP
may also be confounded by inflammation and sTfR by the rate of
erythropoesis. In our infant population,CRPcorrelated significantly
with SF but not with sTfR and ZPP. In a multiple regression model,
CRP and the cytokines together explained SF with an R2 of.345
(P,0.005), whereas sTfR and ZPP were not predicted by CRP and
thecytokines.Thus, thesedatasuggest sTfRandZPParesuitable iron
biomarkers in this agegroupand setting, but standardized cut-offs for
infants are needed [34–36].
CRP, a downstream biomarker of inflammation, was a major
predictor of serum hepcidin in our infant population. IL-6 induces
hepcidin expression [37,38] and it is thought that the increase in
circulating hepcidin during infection/inflammation is primarily
mediated by IL-6 [23]. The inclusion of IL-6 in our regression
analysis significantly increased the variance in serum hepcidin
explained by the model (R2= .587). CRP and IL-6 together
showed an adjusted R2 of.228, while the adjusted R2 of CRP and
IL-6 alone was.199 and.162, respectively. These data suggest other
factors, along with IL-6, may increase CRP during inflammation;
however, IL-6 was the only cytokine with a significant correlation
with serum hepcidin in our models.
Fecal calprotectin (FC), a biomarker of localized gut inflamma-
tion, was correlated with the report of recent blood or mucus in
the infant stool. Similarly, there was a borderline significant trend
for a correlation of FC with the few cases of diarrhea reported in
this population at the time of assessment. However, FC was not
correlated with systemic inflammation, as measured by CRP or
the cytokines. Especially, IL-12 and IL-17, which have been linked
to gut inflammation [39,40], did not show any correlation with
FC. Furthermore, FC, IL-12 and IL-17 were not correlated with
serum hepcidin, suggesting that gut inflammation is not a
predictor for hepcidin in this population. It should however be
noted that, except for IL-6, none of the other measured cytokines
were correlated with hepcidin. Gut inflammation has been
associated with an IL-6-mediated hepcidin increase in a mouse
model for intestinal colitis, but results in humans with inflamma-
tory bowel disease (IBD) are equivocal [41]. The young age of the
Kenyan infants, which is associated with a developing gut
microbiota and immature intestinal immune system [42], might
play a role in the absence of hepcidin induction in the infants with
increased FC levels. Higher values of FC have been reported in
breastfed compared to formula fed Italian infants [43], however, in
our population duration of breastfeeding did not predict FC. The
younger Italian infants (2–13 weeks) showed median FC concen-
tration of 555 mg/kg, thrice as high than in our Kenyan infant
population (167.1 mg/kg) [43]. However, healthy Ugandan
infants aged 0–1 years had a median FC of 249 mg/kg, similar
to our study population [44].
The present study provides important data on serum hepcidin
concentration in iron replete, iron deficient, and iron deficient
anemic infants in rural sub-Saharan Africa. We also propose a
gender-specific reference values for serum hepcidin measured by
WCX-TOF MS in healthy, full-term, iron replete, non-anemic
African infants. The association of hepcidin with iron status and
infection markers in infancy indicates the potential relevance of
hepcidin as iron status marker in this population group. Our data
shows significant differences in hepcidin concentration in IDA
infants with and without inflammation. However, a separate
analysis of this subgroup by sex resulted in significant differences in
boys, but not in girls. Furthermore the size of the differences and
the relatively large standard deviations also suggest that serum
hepcidin alone may not provide sufficient discriminatory power
between anemic infants with and without inflammation (Figure 1).
Thus, because provision of iron to infants with infections may be
dangerous in certain settings, more research is clearly needed on
Table 5. Reference values for serum hepcidin (nM and ng/
mL) from non-anemic, iron replete, Kenyan infants without
elevated CRP (CRP,4.1 mg/L AND SF $12 ng/mL AND sTfR
,7.4 mg/L AND Hb $110 g/L).
95% reference range
Geometric Mean P2.5 P97.5
Male (n =29) nM 1.5 0.0 5.3
ng/mL 4.1 0.1 14.8
Female (n =39) nM 3.2 0.1 18.2
ng/mL 9.0 0.3 50.1
All (n =68) nM 2.3 0.1 18.1
ng/mL 6.4 0.2 50.6
doi:10.1371/journal.pone.0057513.t005
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the potential utility of hepcidin as a point-of-care marker to
increase the safety of iron supplementation in infants and children
in the developing world, as has been proposed [12,13]. In
addition, our data suggest serum hepcidin is not correlated with
gut inflammation during infancy; thus, the potential local injurious
effect of dietary iron supplements on infectious or inflammatory
intestinal disease [45,46] may not be predicted by serum hepcidin
levels. In conclusion, although promising, our study underscores
that the potential clinical advantage of serum hepcidin to guide
safe iron supplementation in infancy needs further clarification.
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